Gene · 11274
Papers1,718
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1 to 20 of 1,718
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A novel stop-loss variant in ISG15 causes C-terminal dysfunction and impairs USP18-mediated negative feedback. | Front Immunol | 2026 | 42824448 | PubTator, text mining | PubMed |
| Sequential exposure to histological chorioamnionitis and postnatal hyperoxia alters gene expression in cord blood monocytes. | Front Pediatr | 2026 | 42812615 | PubTator, text mining | PubMed |
| Organelle-centered ISG15 biology: distinguishing covalent ISGylation from interferon-associated responses. | Front Immunol | 2026 | 42757191 | PubTator, text mining | PubMed |
| piRNA-46403 Promotes Sertoli Cell Ferroptosis via Disrupting m5C-dependent USP18 mRNA Stabilization in Varicocele-mediated Infertility. | Int J Biol Sci | 2026 | 42695002 | PubTator, text mining | PubMed |
| Regulators of interferon-responsive microglia uncovered by Genome-wide CRISPRi screening. | NPJ Dement | 2026 | 42694111 | PubTator, text mining | PubMed |
| Clinicopathological significance and exploratory prognostic modeling of USP18 and YBX3 expression in clear cell renal cell carcinoma: a retrospective Chinese cohort study. | Front Oncol | 2026 | 42614232 | PubTator, text mining | PubMed |
| SR-A3 Promotes USP18-Mediated deISGylation of STING to Protect Against Myocardial Ischemia-Reperfusion Injury. | Adv Sci (Weinh) | 2026 | 42606110 | PubTator, text mining | PubMed |
| Transcription factor EN1 governs a lipogenic USP18-ACLY axis to drive bladder cancer malignancy. | Oncogene | 2026 | 42521834 | PubTator, text mining | PubMed |
| Familial pulmonary alveolar proteinosis and type I interferonopathy by mutation of STAT2 (TIMS2). | J Exp Med | 2026 | 42461263 | PubTator, text mining | PubMed |
| Repeated aminoglycoside exposure activates interferon-stimulated genes in human renal proximal tubular models. | Arch Toxicol | 2026 | 42446670 | PubTator, text mining | PubMed |
| Understanding protein ISGylation, a multifaceted posttranslational modification. | Cell Chem Biol | 2026 | 42442365 | PubTator, text mining | PubMed |
| USP18 regulates skeletal muscle regeneration independently of its deISGylation activity. | Biochim Biophys Acta Mol Basis Dis | 2026 | 42431519 | PubTator, text mining | PubMed |
| USP18-driven macrophage M2 polarization through fatty acid β-oxidation inhibits immune responses induced by RSV infection. | J Infect Dev Ctries | 2026 | 42430541 | PubTator, text mining | PubMed |
| ISGylation-mediated stabilization of CYP4Z1 fuels breast cancer initiation and progression. | Exp Mol Med | 2026 | 42393313 | PubTator, text mining | PubMed |
| USP18 Impacts Cisplatin Resistance in Ovarian Cancer Cells by Modulating DNA Repair. | Int J Biol Sci | 2026 | 42328450 | PubTator, text mining | PubMed |
| USP24 is a cross-reactive DUB targeting MOV10 to regulate IFN-I production. | Nat Commun | 2026 | 42321163 | PubTator, text mining | PubMed |
| Gene expression profiling of dendritic cell tolerance dysfunction in women with systemic lupus erythematosus. | Front Immunol | 2026 | 42311689 | PubTator, text mining | PubMed |
| Identification of macrophage polarization-related genes for esophageal cancer risk: a multi-omics Mendelian randomization analysis. | Clin Epigenetics | 2026 | 42251386 | PubTator, text mining | PubMed |
Multi-omics and machine learning uncover the MX1-ISG15-STAT1 synergistic axis as the core interferon signature in systemic lupus erythematosus and identify herbal-derived multi-target therapeutic candidates. | Comput Biol Chem | 2026 | 42241839 | PubTator, text mining | PubMed |
| WITHDRAWN: USP18-FTO axis activates PI3K-AKT signaling to drive endometrial carcinoma progression. | Int J Biol Macromol | 2026 | 42229644 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/11274/papers